Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Nicod

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Patient|October 10, 2022
Improving Interpretation of Evidence Relating to Quality of Life in Health Technology Assessments of Rare Disease TreatmentsElena Nicod, Andrew J Lloyd, Thomas Morel, et al.
Retina (Philadelphia, Pa.)|September 10, 2013
Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacyTimothy L Jackson, Elena Nicod, Aris Angelis, et al.
Retina (Philadelphia, Pa.)|April 18, 2013
Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysisTimothy L Jackson, Elena Nicod, Aris Angelis, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 26, 2015
Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approachElena Nicod, Timothy L Jackson, Federico Grimaccia, et al.
BMJ Open|February 18, 2019
Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancerOriana Ciani, Maria Cucciniello, Francesco Petracca, et al.
Pharmacoeconomics|July 7, 2021
Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and TisagenlecleucelKaren M Facey, Jaime Espin, Emma Kent, et al.
Orphanet Journal of Rare Diseases|March 12, 2017
Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL)Lieven Annemans, Ségolène Aymé, Yann Le Cam, et al.
Journal of Community Genetics|July 1, 2026
Rare disease genomics and justice: overview of a workshop at the Fondation Brocher, 22-24 January 2025Angus Clarke, Ruth Horn, Elena Avram, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Patient|October 10, 2022
Improving Interpretation of Evidence Relating to Quality of Life in Health Technology Assessments of Rare Disease TreatmentsElena Nicod, Andrew J Lloyd, Thomas Morel, et al.
Retina (Philadelphia, Pa.)|September 10, 2013
Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacyTimothy L Jackson, Elena Nicod, Aris Angelis, et al.
Retina (Philadelphia, Pa.)|April 18, 2013
Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysisTimothy L Jackson, Elena Nicod, Aris Angelis, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 26, 2015
Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approachElena Nicod, Timothy L Jackson, Federico Grimaccia, et al.
BMJ Open|February 18, 2019
Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancerOriana Ciani, Maria Cucciniello, Francesco Petracca, et al.
Pharmacoeconomics|July 7, 2021
Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and TisagenlecleucelKaren M Facey, Jaime Espin, Emma Kent, et al.
Orphanet Journal of Rare Diseases|March 12, 2017
Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL)Lieven Annemans, Ségolène Aymé, Yann Le Cam, et al.
Journal of Community Genetics|July 1, 2026
Rare disease genomics and justice: overview of a workshop at the Fondation Brocher, 22-24 January 2025Angus Clarke, Ruth Horn, Elena Avram, et al.
Pageof 3